Antidepressant Medication Plus Directly Observed Therapy for Improving Adherence to Antiretroviral Therapy

PHASE2CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

January 31, 2001

Primary Completion Date

August 31, 2006

Study Completion Date

August 31, 2006

Conditions
HIV InfectionsDepression
Interventions
BEHAVIORAL

Directly Observed Therapy (DOT)

DOT includes storefront directly observed therapy of prescribed anti-depressants. Participants will meet with a study psychiatrist, who will prescribe an appropriate antidepressant medication. Subsequent meetings with the psychiatrist will occur weekly for the first 3 weeks, and then monthly for the duration of the study. Additionally, participants will have DOT visits every weekday morning for 1 month to take their antidepressant medications. After the first month, DOT visits will occur weekly or biweekly, depending on the medication regimen.

DRUG

Fluoxetine

Medication treatment includes flouxetine for treatment of depression.

Trial Locations (1)

94102

UCSF Market Street Study Site, San Francisco

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Massachusetts General Hospital

OTHER

NCT00338767 - Antidepressant Medication Plus Directly Observed Therapy for Improving Adherence to Antiretroviral Therapy | Biotech Hunter | Biotech Hunter